ADMB-3TMS-PRINACA
ADMB-3TMS-PRINACA[edit | edit source]
ADMB-3TMS-PRINACA is a synthetic cannabinoid that has been identified in various designer drug products. It is part of the indazole-3-carboxamide family, which is known for its potent activity at the cannabinoid receptors. These compounds are often used recreationally for their psychoactive effects, mimicking those of tetrahydrocannabinol (THC), the active component in cannabis.
Chemical Structure and Properties[edit | edit source]
ADMB-3TMS-PRINACA is characterized by its indazole core structure, which is substituted at the 1-position with a 3,3-dimethylbutanoyl group and at the 3-position with a 3-(trimethylsilyl)propyl group. This specific configuration contributes to its high affinity for the cannabinoid receptors, particularly CB1 and CB2.
The chemical formula of ADMB-3TMS-PRINACA is C23H36N2O2Si, and it has a molecular weight of 400.63 g/mol. The presence of the trimethylsilyl group is notable, as it is a common feature in synthetic cannabinoids designed to evade legal restrictions by altering the chemical structure slightly while maintaining psychoactive properties.
Pharmacology[edit | edit source]
ADMB-3TMS-PRINACA acts as a potent agonist at the cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including mood, memory, appetite, and pain sensation. The activation of these receptors by synthetic cannabinoids can lead to effects similar to those of THC, such as euphoria, relaxation, and altered perception.
However, synthetic cannabinoids like ADMB-3TMS-PRINACA can also produce severe adverse effects, including tachycardia, hypertension, hallucinations, and psychosis. The potency and unpredictable nature of these compounds pose significant health risks to users.
Legal Status[edit | edit source]
Due to their potential for abuse and harmful effects, many synthetic cannabinoids, including ADMB-3TMS-PRINACA, have been classified as controlled substances in various jurisdictions. Regulatory agencies continue to monitor and update the legal status of these compounds as new variants are developed and identified.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
